Compare Spinal Modulation vs SteadyMed Therapeutics
Customers evaluate the quality of Spinal Modulation's products using the following success metrics.
Overview
Spinal Modulation is based in United States
Spinal Modulation is dedicated to improving the lives of patients with chronic pain by providing the next generation of neuromodulation systems through stimulation of the dorsal root ganglion. The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
SteadyMed Therapeutics is based in United States
SteadyMed Therapeutics is a drug delivery therapeutics company engaged in the development for commercialization of its prefilled, size efficient and disposable PatchPump technology. The company's range of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner.
Demo Video
Leadership
David Wood (Chief Executive Officer, President)
Ian Solomon (Founder)
Investors
St. Jude Medical, De Novo Ventures
United Therapeutics, Square 1 Bank
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Spinal Modulation has not claimed their profile.
Work for Spinal Modulation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Spinal Modulation?
Claim your profile now.
Information not available because SteadyMed Therapeutics has not claimed their profile.
Work for SteadyMed Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for SteadyMed Therapeutics?
Claim your profile now.